avapro and pd 123319
avapro has been researched along with pd 123319 in 16 studies
Research
Studies (16)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Doerr, G; Fleck, E; Graf, K; Kappert, K; Schmidt, G; Wollert-Wulf, B | 1 |
| Cody, RJ; Goetze, S; Graf, K; Hsueh, WA; Kawano, H; Kawano, Y; Law, RE; Schnee, J | 1 |
| Danser, AH; de Vries, R; MaassenVanDenBrink, A; Saxena, PR; Schalekamp, MA | 1 |
| Danser, AH; de Vries, R; Saxena, PR; Schuijt, MP | 1 |
| Casado, S; Farré, J; Gómez, J; Jiménez, A; López-Blaya, A; López-Farré, A; Montón, M; Núñez, A; Sánchez de Miguel, L; Zalba, LR | 1 |
| El Mabrouk, M; He, G; Schiffrin, EL; Touyz, RM | 1 |
| Mercure, C; Reudelhuber, TL; Touyz, RM | 1 |
| Basdew, M; Danser, AH; de Vries, R; Saxena, PR; Schoemaker, RG; Schuijt, MP; van Veghel, R | 1 |
| Danser, AH; de Vries, R; Saxena, PR; Schalekamp, MA; Schuijt, MP | 1 |
| Balt, JC; Mathy, MJ; Nap, A; Pfaffendorf, M; van Zwieten, PA | 1 |
| Balt, JC; Nap, A; Pfaffendorf, M; Zwieten, PA | 1 |
| Batenburg, WW; Bernasconi, CC; Danser, AH; Garrelds, IM; Juillerat-Jeanneret, L; Saxena, PR; van Kats, JP | 1 |
| Balfagón, G; Gordillo-Moscoso, A; Padilla, E; Redondo, S; Ruiz, E; Salaices, M; Tejerina, T | 1 |
| Danser, AH; Moltzer, E; van Esch, JH; van Veghel, R; Verkuil, AV | 1 |
| Barden, A; Beilin, LJ; Croft, KD; Puddey, IB; Tsai, IJ | 1 |
| Abd-Alla, N; Batenburg, WW; Danser, AH; Durik, M; Roks, AJ; van den Bogaerdt, AJ; van Esch, JH; van Veghel, R; Verdonk, K | 1 |
Other Studies
16 other study(ies) available for avapro and pd 123319
| Article | Year |
|---|---|
Angiotensin II and PDGF-BB stimulate beta(1)-integrin-mediated adhesion and spreading in human VSMCs.
Topics: Angiotensin II; Anticoagulants; Antigens, CD; Antihypertensive Agents; Aorta; Becaplermin; Biphenyl Compounds; Carcinogens; Cell Adhesion; Cell Movement; Collagen; Culture Techniques; Enzyme Inhibitors; Fibronectins; Flow Cytometry; Gene Expression; Genistein; Humans; Iliac Artery; Imidazoles; Integrin alpha5; Integrin beta1; Irbesartan; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetradecanoylphorbol Acetate; Tetrazoles; Vasoconstrictor Agents | 2000 |
Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
Topics: Actinin; Age Factors; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antigens, CD; Antihypertensive Agents; Biphenyl Compounds; Cardiomegaly; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Collagen; Fibroblasts; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Heart Ventricles; Hydralazine; Imidazoles; Integrin alphaV; Integrin beta Chains; Integrin beta1; Integrin beta3; Integrins; Irbesartan; Laminin; Losartan; Myocardium; Phosphorylation; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Up-Regulation; Vitronectin | 2000 |
Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Captopril; Child; Child, Preschool; Chymases; Coronary Vessels; Culture Techniques; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Imidazoles; Irbesartan; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Pyridines; Serine Endopeptidases; Swine; Tetrazoles; Vasoconstriction | 1999 |
No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats.
Topics: Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Hemodynamics; Imidazoles; Irbesartan; Male; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reference Values; Tetrazoles; Vasomotor System | 1999 |
Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antibodies, Monoclonal; Benzimidazoles; Benzoates; Binding, Competitive; Biphenyl Compounds; Blood Platelets; Dose-Response Relationship, Drug; Humans; Imidazoles; Irbesartan; Losartan; Platelet Activation; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Telmisartan; Tetrazoles; Thromboxane A2; Time Factors; Valine; Valsartan | 2000 |
p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cells, Cultured; Collagen; Enzyme Activation; Hypertension; Imidazoles; Irbesartan; Male; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Procollagen; Proline; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Thymidine | 2001 |
Angiotensin II type I receptor modulates intracellular free Mg2+ in renally derived cells via Na+-dependent Ca2+-independent mechanisms.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Amiloride; Angiotensin II; Animals; Antihypertensive Agents; Benzofurans; Biphenyl Compounds; Calcium; Calcium Channel Agonists; Cell Line; Cells, Cultured; Chelating Agents; Cytosol; Dogs; Dose-Response Relationship, Drug; Egtazic Acid; Ethers, Cyclic; Fluorescent Dyes; Fura-2; Imidazoles; Imipramine; Irbesartan; Kidney; Kinetics; Magnesium; Microscopy, Fluorescence; Peptides; Pyridines; Quinidine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium; Tetrazoles; Time Factors | 2001 |
AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiac Output; Coronary Circulation; Heart Failure; Heart Rate; Imidazoles; Irbesartan; Male; Myocardial Infarction; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Circulation; Survival Rate; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2001 |
Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Dose-Response Relationship, Drug; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Isoquinolines; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents | 2002 |
Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Decerebrate State; Diastole; Dose-Response Relationship, Drug; Electric Stimulation; Heart Rate; Imidazoles; Irbesartan; Male; Norepinephrine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Saralasin; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles | 2002 |
No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Drug Synergism; Electric Stimulation; Imidazoles; In Vitro Techniques; Irbesartan; Male; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Tritium; Vasoconstrictor Agents; Vena Cava, Inferior | 2003 |
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Biphenyl Compounds; Child; Child, Preschool; Coronary Circulation; Coronary Vessels; Cyclic GMP; Female; Humans; Imidazoles; Irbesartan; Male; Microcirculation; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; RNA, Messenger; Tetrazoles; Vasodilation | 2004 |
Importance of intracellular angiotensin II in vascular smooth muscle cell apoptosis: inhibition by the angiotensin AT1 receptor antagonist irbesartan.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Arsenicals; Biphenyl Compounds; Blotting, Western; Caspase 3; DNA Fragmentation; Flow Cytometry; Fluorescent Antibody Technique; Imidazoles; Irbesartan; Male; Muscle, Smooth, Vascular; Pyridines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Tetrazoles; Transfection | 2007 |
Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation.
Topics: Analysis of Variance; Angiotensin II; Angiotensin III; Animals; Aorta, Abdominal; Biphenyl Compounds; Coronary Circulation; Disease Models, Animal; Iliac Artery; Imidazoles; Irbesartan; Male; Probability; Pyridines; Random Allocation; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 2; Reference Values; Tetrazoles; Vasoconstriction; Vasodilation | 2010 |
20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1.
Topics: Adult; Aged; Amidines; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Platelets; Calcium Channels; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endothelin-1; Humans; Hydroxyeicosatetraenoic Acids; Imidazoles; Ionophores; Irbesartan; Male; Middle Aged; Neutrophils; Oligopeptides; Peptides, Cyclic; Piperidines; Pyridines; Tetrazoles; Young Adult | 2011 |
Compound 21 induces vasorelaxation via an endothelium- and angiotensin II type 2 receptor-independent mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Angiotensin II Type 2 Receptor Blockers; Animals; Biphenyl Compounds; Calcium; Calcium Ionophores; Coronary Vessels; Endothelium, Vascular; Female; Humans; Iliac Artery; Imidazoles; In Vitro Techniques; Irbesartan; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Models, Animal; Phenylephrine; Pyridines; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonamides; Tetrazoles; Thiophenes; Vasoconstrictor Agents; Vasodilation | 2012 |